Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors.

Clinical trial NCT05905341 · WITHDRAWN

Trial details

NCT number: NCT05905341
Sponsor: Pfizer
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Ovarian Cancer Liposarcoma Non-small Cell Lung Cancer (NSCLC)Endometrial Solid Tumors

Start date: 2024-01-15
Primary completion: 2026-04-14
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.